[Intraarterial therapy of maxillary adenoid cystic carcinoma using cis-platinum (author's transl)].

Abstract

A woman suffering from extended maxillary adenoid cystic carcinoma of mixed cribriform solid type was treated by selective intraarterial infusion of Cisplatinum using a new intraarterial infusion technique. Within four weeks--the entire dosage of Cisplatinum was 400 mg--the patient came into complete remission, clinically and histologically, suggesting that the adenoid cystic carcinoma may be more susceptible to chemotherapy than thought up to the present day. However, primary chemotherapy should be followed by radiotherapy or surgical treatment.

• Authors: J von Scheel, E R Kastenbauer
• Journal: HNO (HNO) Vol. 29 Issue 9 Pg. 308-11 (Sep 1981) ISSN: 0017-6192 [Print] Germany
• Vernacular Title: Intraarterielle Cisplatin-Therapie beim adenoid-zystischen Karzinom.
• PMID: 6274831 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Cisplatin

Topics

• Adenoids (blood supply, pathology)
• Carcinoma, Adenoid Cystic (drug therapy)
• Cisplatin (administration & dosage, therapeutic use)
• Female
• Humans
• Infusions, Intra-Arterial
• Maxilla (blood supply)
• Methods
• Middle Aged